Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

A comprehensive PDX gastric cancer collection captures cancer cell intrinsic transcriptional MSI traits.

Corso S, Isella C, Bellomo SE, Apicella M, Durando S, Migliore C, Ughetto S, D'Errico L, Menegon S, Moya-Rull D, Cargnelutti M, Capeloa T, Conticelli D, Giordano J, Venesio T, Balsamo A, Marchiò C, Degiuli M, Reddavid R, Fumagalli Romario U, de Pascale S, Sgroi G, Rausa E, Baiocchi GL, Molfino S, Pietrantonio F, Morano F, Siena S, Sartore-Bianchi A, Bencivenga M, Mengardo V, Rosati R, Marrelli D, Morgagni P, Rausei S, Pallabazzer G, De Simone M, Ribero D, Marsoni S, Sottile A, Medico E, Cassoni P, Sapino A, Pectasides E, Thorner AR, Nag A, Drinan SD, Wollison BM, Bass AJ, Giordano S.

Cancer Res. 2019 Oct 4. pii: canres.1166.2019. doi: 10.1158/0008-5472.CAN-19-1166. [Epub ahead of print]

PMID:
31585941
2.

Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3.

Ballabio S, Craparotta I, Paracchini L, Mannarino L, Corso S, Pezzotta MG, Vescio M, Fruscio R, Romualdi C, Dainese E, Ceppi L, Calura E, Pileggi S, Siravegna G, Pattini L, Martini P, Delle Marchette M, Mangioni C, Ardizzoia A, Pellegrino A, Landoni F, D'Incalci M, Beltrame L, Marchini S.

Int J Cancer. 2019 Nov 15;145(10):2670-2681. doi: 10.1002/ijc.32288. Epub 2019 Apr 26.

PMID:
30892690
3.

The landscape of d16HER2 splice variant expression across HER2-positive cancers.

Volpi CC, Pietrantonio F, Gloghini A, Fucà G, Giordano S, Corso S, Pruneri G, Antista M, Cremolini C, Fasano E, Saggio S, Faraci S, Di Bartolomeo M, de Braud F, Di Nicola M, Tagliabue E, Pupa SM, Castagnoli L.

Sci Rep. 2019 Mar 5;9(1):3545. doi: 10.1038/s41598-019-40310-5.

4.

Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies.

Apicella M, Giannoni E, Fiore S, Ferrari KJ, Fernández-Pérez D, Isella C, Granchi C, Minutolo F, Sottile A, Comoglio PM, Medico E, Pietrantonio F, Volante M, Pasini D, Chiarugi P, Giordano S, Corso S.

Cell Metab. 2018 Dec 4;28(6):848-865.e6. doi: 10.1016/j.cmet.2018.08.006. Epub 2018 Aug 30.

PMID:
30174307
5.

Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts.

Corso S, Cargnelutti M, Durando S, Menegon S, Apicella M, Migliore C, Capeloa T, Ughetto S, Isella C, Medico E, Bertotti A, Sassi F, Sarotto I, Casorzo L, Pisacane A, Mangioni M, Sottile A, Degiuli M, Fumagalli U, Sgroi G, Molfino S, De Manzoni G, Rosati R, De Simone M, Marrelli D, Saragoni L, Rausei S, Pallabazzer G, Roviello F, Cassoni P, Sapino A, Bass A, Giordano S.

Neoplasia. 2018 May;20(5):443-455. doi: 10.1016/j.neo.2018.02.003. Epub 2018 Mar 23.

6.

Determinants of Peripheral Muscle Strength and Activity in Daily Life in People With Bronchiectasis.

de Camargo AA, Boldorini JC, Holland AE, de Castro RAS, Lanza FC, Athanazio RA, Rached SZ, Carvalho-Pinto R, Cukier A, Stelmach R, Corso SD.

Phys Ther. 2018 Mar 1;98(3):153-161. doi: 10.1093/ptj/pzx123.

PMID:
29237078
7.

Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients: the AMNESIA Case-Control Study.

Pietrantonio F, Fucà G, Morano F, Gloghini A, Corso S, Aprile G, Perrone F, De Vita F, Tamborini E, Tomasello G, Gualeni AV, Ongaro E, Busico A, Giommoni E, Volpi CC, Laterza MM, Corallo S, Prisciandaro M, Antista M, Pellegrinelli A, Castagnoli L, Pupa SM, Pruneri G, de Braud F, Giordano S, Cremolini C, Di Bartolomeo M.

Clin Cancer Res. 2018 Mar 1;24(5):1082-1089. doi: 10.1158/1078-0432.CCR-17-2781. Epub 2017 Dec 5.

8.

YAP-Dependent AXL Overexpression Mediates Resistance to EGFR Inhibitors in NSCLC.

Ghiso E, Migliore C, Ciciriello V, Morando E, Petrelli A, Corso S, De Luca E, Gatti G, Volante M, Giordano S.

Neoplasia. 2017 Dec;19(12):1012-1021. doi: 10.1016/j.neo.2017.10.003. Epub 2017 Nov 11.

9.

Comparison of Robotic and laparoscopic Radical type-B and C hysterectomy for cervical cancer: Long term-outcomes.

Pellegrino A, Damiani GR, Loverro M, Pirovano C, Fachechi G, Corso S, Trojano G.

Acta Biomed. 2017 Oct 23;88(3):289-296. doi: 10.23750/abm.v88i3.6100.

10.

Targeted therapies for gastric cancer: failures and hopes from clinical trials.

Apicella M, Corso S, Giordano S.

Oncotarget. 2017 Jan 26;8(34):57654-57669. doi: 10.18632/oncotarget.14825. eCollection 2017 Aug 22. Review.

11.

Does home-based pulmonary rehabilitation improve functional capacity, peripheral muscle strength and quality of life in patients with bronchiectasis compared to standard care?

José A, Holland AE, Oliveira CS, Selman JPR, Castro RAS, Athanazio RA, Rached SZ, Cukier A, Stelmach R, Corso SD.

Braz J Phys Ther. 2017 Nov - Dec;21(6):473-480. doi: 10.1016/j.bjpt.2017.06.021. Epub 2017 Aug 19.

12.

Erratum to: Effects of periodontal treatment on exacerbation frequency and lung function in patients with chronic periodontitis: study protocol of a 1-year randomized controlled trial.

Romero SD, Pinto EH, Longo PL, Corso SD, Lanza FC, Stelmach R, Rached SZ, Lino-Dos-Santos-Franco A, Mayer MP, Bussadori SK, Fernandes KP, Mesquita-Ferrari RA, Horliana AC.

BMC Pulm Med. 2017 Mar 14;17(1):51. doi: 10.1186/s12890-017-0394-6. No abstract available.

13.

Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancer.

Fruscio R, Ceppi L, Corso S, Galli F, Dell'Anna T, Dell'Orto F, Giuliani D, Garbi A, Chiari S, Mangioni C, Milani R, Floriani I, Colombo N, Bonazzi CM.

Br J Cancer. 2016 Sep 6;115(6):641-8. doi: 10.1038/bjc.2016.254. Epub 2016 Aug 18.

14.

Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort.

Apicella M, Migliore C, Capelôa T, Menegon S, Cargnelutti M, Degiuli M, Sapino A, Sottile A, Sarotto I, Casorzo L, Cassoni P, De Simone M, Comoglio PM, Marsoni S, Corso S, Giordano S.

Oncogene. 2017 Mar 2;36(9):1200-1210. doi: 10.1038/onc.2016.283. Epub 2016 Aug 15.

PMID:
27524418
15.

Cost analysis of minimally invasive hysterectomy vs open approach performed by a single surgeon in an Italian center.

Pellegrino A, Damiani GR, Fachechi G, Corso S, Pirovano C, Trio C, Villa M, Turoli D, Youssef A.

J Robot Surg. 2017 Jun;11(2):115-121. doi: 10.1007/s11701-016-0625-5. Epub 2016 Jul 26.

PMID:
27460843
16.

SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer.

Nahleh ZA, Barlow WE, Hayes DF, Schott AF, Gralow JR, Sikov WM, Perez EA, Chennuru S, Mirshahidi HR, Corso SW, Lew DL, Pusztai L, Livingston RB, Hortobagyi GN.

Breast Cancer Res Treat. 2016 Aug;158(3):485-95. doi: 10.1007/s10549-016-3889-6. Epub 2016 Jul 8.

17.

How Can Gastric Cancer Molecular Profiling Guide Future Therapies?

Corso S, Giordano S.

Trends Mol Med. 2016 Jul;22(7):534-544. doi: 10.1016/j.molmed.2016.05.004. Epub 2016 May 31.

18.

Tamoxifen Dose Escalation in Patients With Diminished CYP2D6 Activity Normalizes Endoxifen Concentrations Without Increasing Toxicity.

Hertz DL, Deal A, Ibrahim JG, Walko CM, Weck KE, Anderson S, Magrinat G, Olajide O, Moore S, Raab R, Carrizosa DR, Corso S, Schwartz G, Graham M, Peppercorn JM, Jones DR, Desta Z, Flockhart DA, Evans JP, McLeod HL, Carey LA, Irvin WJ Jr.

Oncologist. 2016 Jul;21(7):795-803. doi: 10.1634/theoncologist.2015-0480. Epub 2016 May 25.

19.

Outcomes of Bleomycin-based electrochemotherapy in patients with repeated loco-regional recurrences of vulvar cancer.

Pellegrino A, Damiani GR, Mangioni C, Strippoli D, Loverro G, Cappello A, Turoli Scd D, Corso S, Tartagni M, Pezzotta MG.

Acta Oncol. 2016 May;55(5):619-24. doi: 10.3109/0284186X.2015.1117134. Epub 2016 Feb 17.

PMID:
26882959
20.

In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles.

Hertz DL, Snavely AC, McLeod HL, Walko CM, Ibrahim JG, Anderson S, Weck KE, Magrinat G, Olajide O, Moore S, Raab R, Carrizosa DR, Corso S, Schwartz G, Peppercorn JM, Evans JP, Jones DR, Desta Z, Flockhart DA, Carey LA, Irvin WJ Jr.

Br J Clin Pharmacol. 2015 Nov;80(5):1122-30. doi: 10.1111/bcp.12665. Epub 2015 Aug 2.

21.

Activation of RAS family members confers resistance to ROS1 targeting drugs.

Cargnelutti M, Corso S, Pergolizzi M, Mévellec L, Aisner DL, Dziadziuszko R, Varella-Garcia M, Comoglio PM, Doebele RC, Vialard J, Giordano S.

Oncotarget. 2015 Mar 10;6(7):5182-94.

22.

Increase of MET gene copy number confers resistance to a monovalent MET antibody and establishes drug dependence.

Martin V, Corso S, Comoglio PM, Giordano S.

Mol Oncol. 2014 Dec;8(8):1561-74. doi: 10.1016/j.molonc.2014.06.010. Epub 2014 Jun 24.

23.

Targeted therapies in cancer and mechanisms of resistance.

Corso S, Giordano S.

J Mol Med (Berl). 2014 Jul;92(7):677-9. doi: 10.1007/s00109-014-1171-0. No abstract available.

24.

Adjuvant chemotherapy in stage I-II uterine leiomyosarcoma: a multicentric retrospective study of 140 patients.

Mancari R, Signorelli M, Gadducci A, Carinelli S, De Ponti E, Sesana S, Corso S, Chiappa V, Colombo N, Lissoni AA.

Gynecol Oncol. 2014 Jun;133(3):531-6. doi: 10.1016/j.ygyno.2014.03.001. Epub 2014 Mar 11.

PMID:
24631454
25.

Patients' understanding of how genotype variation affects benefits of tamoxifen therapy for breast cancer.

Brewer NT, Defrank JT, Chiu WK, Ibrahim JG, Walko CM, Rubin P, Olajide OA, Moore SG, Raab RE, Carrizosa DR, Corso SW, Schwartz G, Peppercorn JM, McLeod HL, Carey LA, Irvin WJ Jr.

Public Health Genomics. 2014;17(1):43-7. doi: 10.1159/000356565. Epub 2014 Jan 22.

26.

Patients hospitalized for community-acquired pneumonia present reduced functional performance.

José A, Corso SD.

Braz J Phys Ther. 2013 Jul-Aug;17(4):351-8. doi: 10.1590/S1413-35552013005000098. Epub 2013 Aug 1.

PMID:
24072224
27.

Reproducibility of step tests in patients with bronchiectasis.

Camargo AA, Lanza FC, Tupinambá T, Corso SD.

Braz J Phys Ther. 2013 May-Jun;17(3):255-62.

PMID:
23966142
28.

Cell-autonomous and non-cell-autonomous mechanisms of HGF/MET-driven resistance to targeted therapies: from basic research to a clinical perspective.

Corso S, Giordano S.

Cancer Discov. 2013 Sep;3(9):978-92. doi: 10.1158/2159-8290.CD-13-0040. Epub 2013 Jul 30. Review.

29.

Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer.

Bardelli A, Corso S, Bertotti A, Hobor S, Valtorta E, Siravegna G, Sartore-Bianchi A, Scala E, Cassingena A, Zecchin D, Apicella M, Migliardi G, Galimi F, Lauricella C, Zanon C, Perera T, Veronese S, Corti G, Amatu A, Gambacorta M, Diaz LA Jr, Sausen M, Velculescu VE, Comoglio P, Trusolino L, Di Nicolantonio F, Giordano S, Siena S.

Cancer Discov. 2013 Jun;3(6):658-73. doi: 10.1158/2159-8290.CD-12-0558. Epub 2013 Jun 2.

30.

EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells.

Stella GM, Scabini R, Inghilleri S, Cemmi F, Corso S, Pozzi E, Morbini P, Valentini A, Dore R, Ferrari S, Luisetti M, Zorzetto M.

J Cancer Res Clin Oncol. 2013 Aug;139(8):1327-35. doi: 10.1007/s00432-013-1444-y. Epub 2013 May 5.

PMID:
23644698
31.

Isobaric laparoscopy using LaparoTenser system in surgical gynecologic oncology.

Pellegrino A, Damiani GR, Tartagni M, Speciale D, Villa M, Sportelli C, Corso S, Pezzotta MG.

J Minim Invasive Gynecol. 2013 Sep-Oct;20(5):686-90. doi: 10.1016/j.jmig.2013.03.006. Epub 2013 Apr 25.

PMID:
23623267
32.

Laparoscopic ablation of hepatocellular carcinoma in cirrhotic patients unsuitable for liver resection or percutaneous treatment: a cohort study.

Cillo U, Vitale A, Dupuis D, Corso S, Neri D, D'Amico F, Gringeri E, Farinati F, Vincenzi V, Zanus G.

PLoS One. 2013;8(2):e57249. doi: 10.1371/journal.pone.0057249. Epub 2013 Feb 21.

33.

Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series.

Fruscio R, Corso S, Ceppi L, Garavaglia D, Garbi A, Floriani I, Franchi D, Cantù MG, Bonazzi CM, Milani R, Mangioni C, Colombo N.

Ann Oncol. 2013 Jan;24(1):138-44. doi: 10.1093/annonc/mds241. Epub 2012 Sep 3.

PMID:
22945381
34.

The use of step tests for the assessment of exercise capacity in healthy subjects and in patients with chronic lung disease.

Andrade CH, Cianci RG, Malaguti C, Corso SD.

J Bras Pneumol. 2012 Jan-Feb;38(1):116-24. Review. English, Portuguese.

35.

[Hardy personality and psychological capital: the positive personal variables and the processes of exhaustion and vigor].

Moreno-Jiménez B, Garrosa E, Corso S, Boada M, Rodríguez-Carvajal R.

Psicothema. 2012 Feb;24(1):79-86. Review. Spanish.

PMID:
22269368
36.

[Use of Simulated Pacients in Psychiatry].

Corso SJ, Delgado MB, Gómez-Restrepo C.

Rev Colomb Psiquiatr. 2012;41S:52S-68S. doi: 10.1016/S0034-7450(14)60179-7. Epub 2014 May 10. Spanish.

PMID:
26572575
37.

Genotype-guided tamoxifen dosing increases active metabolite exposure in women with reduced CYP2D6 metabolism: a multicenter study.

Irvin WJ Jr, Walko CM, Weck KE, Ibrahim JG, Chiu WK, Dees EC, Moore SG, Olajide OA, Graham ML, Canale ST, Raab RE, Corso SW, Peppercorn JM, Anderson SM, Friedman KJ, Ogburn ET, Desta Z, Flockhart DA, McLeod HL, Evans JP, Carey LA.

J Clin Oncol. 2011 Aug 20;29(24):3232-9. doi: 10.1200/JCO.2010.31.4427. Epub 2011 Jul 18.

38.

Peripheral muscle dysfunction in COPD: lower limbs versus upper limbs.

Miranda EF, Malaguti C, Corso SD.

J Bras Pneumol. 2011 May-Jun;37(3):380-8. Review. English, Portuguese.

39.

Expression of DNA repair genes in ovarian cancer samples: biological and clinical considerations.

Ganzinelli M, Mariani P, Cattaneo D, Fossati R, Fruscio R, Corso S, Ricci F, Broggini M, Damia G.

Eur J Cancer. 2011 May;47(7):1086-94. doi: 10.1016/j.ejca.2010.11.029. Epub 2011 Jan 7.

PMID:
21216588
40.

The tetraspanin CD151 is required for Met-dependent signaling and tumor cell growth.

Franco M, Muratori C, Corso S, Tenaglia E, Bertotti A, Capparuccia L, Trusolino L, Comoglio PM, Tamagnone L.

J Biol Chem. 2010 Dec 10;285(50):38756-64. doi: 10.1074/jbc.M110.145417. Epub 2010 Oct 11.

41.

MET and KRAS gene amplification mediates acquired resistance to MET tyrosine kinase inhibitors.

Cepero V, Sierra JR, Corso S, Ghiso E, Casorzo L, Perera T, Comoglio PM, Giordano S.

Cancer Res. 2010 Oct 1;70(19):7580-90. doi: 10.1158/0008-5472.CAN-10-0436. Epub 2010 Sep 14.

42.

Enhanced c-Met activity promotes G-CSF-induced mobilization of hematopoietic progenitor cells via ROS signaling.

Tesio M, Golan K, Corso S, Giordano S, Schajnovitz A, Vagima Y, Shivtiel S, Kalinkovich A, Caione L, Gammaitoni L, Laurenti E, Buss EC, Shezen E, Itkin T, Kollet O, Petit I, Trumpp A, Christensen J, Aglietta M, Piacibello W, Lapidot T.

Blood. 2011 Jan 13;117(2):419-28. doi: 10.1182/blood-2009-06-230359. Epub 2010 Jun 28.

43.

Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition.

Corso S, Ghiso E, Cepero V, Sierra JR, Migliore C, Bertotti A, Trusolino L, Comoglio PM, Giordano S.

Mol Cancer. 2010 May 26;9:121. doi: 10.1186/1476-4598-9-121.

44.

Bone density in children treated with gonadotropin-releasing hormone analogs for central precocious puberty.

Antoniazzi F, Monti E, Gaudino R, Cavarzere P, Zaffanello M, Brugnara M, Perlini S, Maines E, Gallo MC, Corso SD, Zanon D, Tatò L.

Expert Rev Endocrinol Metab. 2010 Mar;5(2):285-290. doi: 10.1586/eem.09.82.

PMID:
30764052
45.

Only a subset of Met-activated pathways are required to sustain oncogene addiction.

Bertotti A, Burbridge MF, Gastaldi S, Galimi F, Torti D, Medico E, Giordano S, Corso S, Rolland-Valognes G, Lockhart BP, Hickman JA, Comoglio PM, Trusolino L.

Sci Signal. 2009;2(102):er11.

PMID:
20039471
46.

Only a subset of Met-activated pathways are required to sustain oncogene addiction.

Bertotti A, Burbridge MF, Gastaldi S, Galimi F, Torti D, Medico E, Giordano S, Corso S, Rolland-Valognes G, Lockhart BP, Hickman JA, Comoglio PM, Trusolino L.

Sci Signal. 2009 Dec 8;2(100):ra80. doi: 10.1126/scisignal.2000643. Erratum in: Sci Signal. 2009 Dec 22;2(102):er11. Corrected and republished in: Sci Signal. 2009;2(102):er11.

47.

MicroRNAs impair MET-mediated invasive growth.

Migliore C, Petrelli A, Ghiso E, Corso S, Capparuccia L, Eramo A, Comoglio PM, Giordano S.

Cancer Res. 2008 Dec 15;68(24):10128-36. doi: 10.1158/0008-5472.CAN-08-2148.

48.

Semaphorin 4D regulates gonadotropin hormone-releasing hormone-1 neuronal migration through PlexinB1-Met complex.

Giacobini P, Messina A, Morello F, Ferraris N, Corso S, Penachioni J, Giordano S, Tamagnone L, Fasolo A.

J Cell Biol. 2008 Nov 3;183(3):555-66. doi: 10.1083/jcb.200806160.

49.

Harmonic scalpel versus conventional electrosurgery in the treatment of vulvar cancer.

Pellegrino A, Fruscio R, Maneo A, Corso S, Battistello M, Chiappa V, Stomati M.

Int J Gynaecol Obstet. 2008 Nov;103(2):185-8. doi: 10.1016/j.ijgo.2008.07.004. Epub 2008 Sep 23.

PMID:
18812244
50.

Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages.

Sierra JR, Corso S, Caione L, Cepero V, Conrotto P, Cignetti A, Piacibello W, Kumanogoh A, Kikutani H, Comoglio PM, Tamagnone L, Giordano S.

J Exp Med. 2008 Jul 7;205(7):1673-85. doi: 10.1084/jem.20072602. Epub 2008 Jun 16.

Supplemental Content

Support Center